Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $38.5M | $93.7M | $147.4M | $19.4M | $326.1M | $71.5M | $44.7M | $225.9M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $38.5M | $93.7M | $147.4M | $19.4M | $326.1M | $71.5M | $44.7M | $226.5M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.3% |
| R&D | $140.2M | $207.9M | $191.4M | $258.3M | $325.9M | $390.4M | $457.7M | $503.0M |
| Operating income | −$123.2M | −$137.8M | −$75.5M | −$278.4M | −$50.9M | −$369.9M | −$471.1M | −$350.5M |
| EBITDA | −$118.1M | −$126.5M | −$64.0M | −$263.3M | −$27.1M | −$312.7M | −$460.0M | −$330.7M |
| Net income | −$123.2M | −$139.1M | −$76.7M | −$279.0M | −$34.1M | −$330.3M | −$429.4M | −$332.0M |
| Net margin | -319.5% | -148.4% | -52.0% | -1439.1% | -10.5% | -462.2% | -960.9% | -147.0% |
| EPS (diluted) | -8.91 | -7.53 | -2.67 | -5.15 | -0.55 | -5.02 | -6.53 | -5.07 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $207M | $-8.08 | $-16.45–$1.17 | 1 |
| 2027 | $778M | $3.60 | $-0.52–$7.33 | 1 |
| 2028 | $82M | $-2.24 | $-4.56–$0.32 | 1 |
| 2029 | $40M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
BIOINVENT INTL NEW
No one on the platform currently holds BOVNF.
No tracked institution reports a position in BOVNF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-01-07 | 1-for-25reverse |
No one on the platform has traded BOVNF yet.
| $15M |
| — |
| HLOSFHealios K.K. | $1.80 | +0.00% | $194M | — |
| MDCLFMedinCell S.A. | $34.39 | +0.00% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.